Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

被引：123

作者：

Ashrafizadeh, Milad ^{[1
,2
]}

Mirzaei, Sepideh ^{[3
]}

Gholami, Mohammad Hossein ^{[4
]}

Hashemi, Farid ^{[5
]}

Zabolian, Amirhossein ^{[6
]}

Raei, Mehdi ^{[7
]}

Hushmandi, Kiavash ^{[8
]}

Zarrabi, Ali ^{[2
]}

Voelcker, Nicolas H. ^{[9
,10
,11
]}

Aref, Amir Reza ^{[12
,13
]}

Hamblin, Michael R. ^{[14
,15
]}

Varma, Rajender S. ^{[16
]}

Samarghandian, Saeed ^{[17
]}

Arostegi, I. J. ^{[18
]}

Alzola, M. ^{[18
]}

Kumar, Alan Prem ^{[19
,20
,21
]}

Thakur, Vijay Kumar ^{[22
,23
]}

Nabavi, Noushin ^{[24
,25
]}

Makvandi, Pooyan ^{[26
]}

Tay, Franklin R. ^{[27
]}

Orive, Gorka ^{[18
,28
,29
,30
,31
]}

机构：

[1] Sabanci Univ, Fac Engn & Nat Sci, Univ Caddesi 27, TR-34956 Istanbul, Turkey

[2] Sabanci Univ, Nanotechnol Res & Applicat Ctr SUNUM, TR-34956 Istanbul, Turkey

[3] Islamic Azad Univ, Fac Sci, Dept Biol, Sci & Res Branch, Tehran, Iran

[4] Islamic Azad Univ, Fac Vet Med, Kazerun Branch, Kazerun, Iran

[5] Univ Tehran, Fac Vet Med, Dept Comparat Biosci, Tehran, Iran

[6] Islamic Azad Univ, Tehran Med Sci, Young Researchers & Elite Club, Tehran, Iran

[7] Baqiyatallah Univ Med Sci, Hlth Res Ctr, Life Style Inst, Tehran, Iran

[8] Univ Tehran, Fac Vet Med, Dept Food Hyg & Qual Control, Div Epidemiol, Tehran, Iran

[9] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia

[10] CSIRO, Clayton, Vic 3168, Australia

[11] Victorian Node Australian Natl Fabricat Facil, Melbourne Ctr Nanofabricat, 151 Wellington Rd, Clayton, Vic 3168, Australia

[12] Harvard Med Sch, Belfer Ctr Appl Canc Sci, Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Xsphera Biosci Inc, Dept Translat Sci, Boston, MA USA

[14] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa

[15] Iran Univ Med Sci, Radiobiol Res Ctr, Tehran, Iran

[16] Palacky Univ, Reg Ctr Adv Technol & Mat, Slechtitel 27, Olomouc 78371, Czech Republic

[17] Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran

[18] Univ Basque Country, Sch Pharm, UPV EHU, NanoBioCel Res Grp, Vitoria, Spain

[19] Natl Univ Singapore, NUS Ctr Canc Res N2CR, Yong Loo Lin Sch Med, Singapore 117600, Singapore

[20] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Singapore 117599, Singapore

[21] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117599, Singapore

[22] Scotlands Rural Coll SRUC, Biorefining & Adv Mat Res Ctr, Kings Bldg, Edinburgh EH9 3JG, Midlothian, Scotland

[23] Shiv Nadar Univ, Sch Engn, Dept Mech Engn, Greater Noida 201314, Uttar Pradesh, India

[24] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H3Z6, Canada

[25] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H3Z6, Canada

[26] Ist Italiano Tecnol, Ctr Mat Interfaces, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy

[27] Augusta Univ, Grad Sch, Augusta, GA 30912 USA

[28] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Vitoria, Spain

[29] Univ Basque Country, Univ Inst Regenerat Med & Oral Implantol UIRMI, Fdn Eduardo Anitua, Vitoria, Spain

[30] Bioaraba, NanoBioCel Res Grp, Vitoria, Spain

[31] Singapore Eye Res Inst, 20 Coll Rd,Discovery Tower, Singapore, Singapore

来源：

CARBOHYDRATE POLYMERS | 2021年 / 272卷

基金：

新加坡国家研究基金会;

关键词：

CD44; Doxorubicin; Drug resistance; Endocytosis; Hyaluronic acid; Nanodelivery system; Theranostic; MESOPOROUS SILICA NANOPARTICLES; TARGETED DRUG-DELIVERY; FUNCTIONALIZED GRAPHENE OXIDE; HUMAN GASTRIC-CANCER; LONG NONCODING RNAS; IN-VITRO EVALUATION; LUNG-CANCER; CONTROLLED-RELEASE; CHITOSAN NANOPARTICLES; HYBRID NANOPARTICLES;

D O I：

10.1016/j.carbpol.2021.118491

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

An important motivation for the use of nanomaterials and nanoarchitectures in cancer therapy emanates from the widespread emergence of drug resistance. Although doxorubicin (DOX) induces cell cycle arrest and DNA damage by suppressing topoisomerase activity, resistance to DOX has severely restricted its anti-cancer potential. Hyaluronic acid (HA) has been extensively utilized for synthesizing nanoparticles as it interacts with CD44 expressed on the surface of cancer cells. Cancer cells can take up HA-modified nanoparticles through receptor mediated endocytosis. Various types of nanostructures such as carbon nanomaterials, lipid nanoparticles and polymeric nanocarriers have been modified with HA to enhance the delivery of DOX to cancer cells. Hyaluronic acid-based advanced materials provide a platform for the co-delivery of genes and drugs along with DOX to enhance the efficacy of anti-cancer therapy and overcome chemoresistance. In the present review, the potential methods and application of HA-modified nanostructures for DOX delivery in anti-cancer therapy are discussed.

引用

页数：21

共 50 条

[21] A hyaluronic acid-based nanogel for the co-delivery of nitric oxide (NO) and a novel antimicrobial peptide (AMP) against bacterial biofilms
Fasiku, Victoria O.
Omolo, Calvin A.
Kiruri, Lucy W.
Devnarain, Nikita
Faya, Mbuso
Mocktar, Chunderika
Govender, Thirumala
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 206 : 381 - 397
[22] Development of a manganese complex hyaluronic acid hydrogel encapsulating stimuli-responsive Gambogic acid nanoparticles for targeted Intratumoral delivery
Jing, Yuanhao
Wang, Chun
Li, Chunhua
Wei, Zijian
Lei, Dan
Chen, Anni
Li, Xiang
He, Xiaowen
Cen, Lanqi
Sun, Mengna
Liu, Baorui
Xue, Bin
Li, Rutian
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 270
[23] Multifunctional stimuli-responsive niosomal nanoparticles for co-delivery and co-administration of gene and bioactive compound: In vitro and in vivo studies
Abtahi, Najmeh Alsadat
Naghib, Seyed Morteza
Ghalekohneh, Sina Jafari
Mohammadpour, Zahra
Nazari, Hojjatollah
Mosavi, Seyed Mohammad
Gheibihayat, Seyed Mohammad
Haghiralsadat, Fateme
Reza, Javad Zavar
Doulabi, Behroz Zandieh
CHEMICAL ENGINEERING JOURNAL, 2022, 429
[24] Charge reversible hyaluronic acid-based drug delivery system with pH-responsive dissociation for enhanced drug delivery
Yang, Wenjing
Yan, Ke
Feng, Yecheng
Zhao, Xubo
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 205
[25] Stimuli-responsive terpolymer mPEG-b-PDMAPMA-b-PAH mediated co-delivery of adriamycin and siRNA to enhance anticancer efficacy
Xu, Minghui
Qian, Junmin
Suo, Aili
Xu, Weijun
Liu, Rongrong
Wang, Hongjie
RSC ADVANCES, 2015, 5 (27): : 20890 - 20899
[26] Poly(aspartic acid)-based pH-responsive targeting co-delivery nanoparticles
Li, Qiang
Fu, Dongsheng
Zhang, Jie
Li, Tianyang
Wang, Huifang
Hou, Wenjuan
Niu, Baolong
Guo, Ruijie
Liu, Yiming
JOURNAL OF BIOMATERIALS APPLICATIONS, 2021, 36 (04) : 579 - 591
[27] Photoluminescent folic acid functionalized biocompatible and stimuli-responsive nanostructured polymer brushes for targeted and controlled delivery of doxorubicin
Pooresmaeil, Malihe
Namazi, Hassan
Salehi, Roya
EUROPEAN POLYMER JOURNAL, 2021, 156 (156)
[28] Dual stimuli-responsive polypeptide-calcium phosphate hybrid nanoparticles for co-delivery of multiple drugs in cancer therapy
Li, Qiang
Fu, Dongsheng
Zhang, Jie
Yan, Hong
Wang, Huifang
Niu, Baolong
Guo, Ruijie
Liu, Yiming
COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 200
[29] Stimuli-responsive nanocarrier delivery systems for Pt-based antitumor complexes: a review
Wang, Tianshuai
Wu, Chen
Hu, Yanggen
Zhang, Yan
Ma, Junkai
RSC ADVANCES, 2023, 13 (24) : 16488 - 16511
[30] Drug Delivery Based on Stimuli-Responsive Injectable Hydrogels for Breast Cancer Therapy: A Review
Xin, Hai
Naficy, Sina
GELS, 2022, 8 (01)

← 1 2 3 4 5 →